Jacob Mintz is a professional options trader and editor of Cabot Options Trader. Using his proprietary options scans, Jacob creates and manages positions in equities based on unusual option activity and risk/reward.
Jacob developed his proprietary system during his years as an options market maker on the floor of the Chicago Board of Options Exchange, where he ran several trading crowds for nearly 10 years.
After a successful career on the trading floor Jacob was tasked with setting up a trading desk at a top-tier options trading company, trading against the most sophisticated hedge funds and institutions in the world.
Today Jacob trades for himself, coaches and teaches about options trading, and runs our Cabot Options Trader and Cabot Options Trader Pro advisories. Jacob lives in North Carolina with his wife and two kids who keep him very busy with their sports and social calendars.
Articles by Jacob Mintz
The good news is the election has passed, and there is hope in the race to find a coronavirus vaccine. The bad news is that these two developments aren’t necessarily great news for all stocks, as money viciously rotated yesterday out of hyper-growth and...
This past May, I recommended buying calls in PTON stock. The result was perhaps the greatest options trade I've ever made.
The stay-at-home paradigm has revolutionized the workforce, accelerating demands on the cloud and in telecommunications – including the rollout of next generation 5G wireless networks.
Looking to invest in a good stock that's either young or has long-term turnaround potential? Try LEAP options in these three stocks.
After a dismal 2019, when semiconductor sales fell 12% to $412 billion, the World Semiconductor Trade Statistics organization predicts that they will rise 3.3% in 2020 and 6.2% in 2021. But today's recommendation is doing a lot better than the average chip company.
The healthcare industry has had its share of ups and downs, with most of the attention being showered on the biotechs that hope to produce COVID-19 vaccines. But after the recent outlook upgrade of today's recommendation, investors may want to broaden their healthcare list...